Navigation Links
USPTO Allows NivaSonix Core Patent - 'External Ultrasound Lipoplasty'
Date:2/8/2011

CARPINTERIA, Calif., Feb. 8, 2011 /PRNewswire/ -- NivaSonix, LLC announced today the allowance by the U. S. Patent and Trademark Office (USPTO) of its core patent "External Ultrasound Lipoplasty".  Nine additional U.S. and international patents are pending with additional patent filings in progress.  The patent describes a technology that allows a new generation of non-invasive ultrasound therapy for both fat and wrinkle reduction targeted for patients worldwide.

NivaSonix has successfully developed a unique and differentiating way to selectively deliver ultrasound energy based on its proprietary "Sweeping Multizone Focus™" ("SMF™") technology.  Fully functional prototypes have been built and tested to prove the concept, which has been confirmed via live animal and human tissue testing.  Additional testing to support applications for domestic and international regulatory approvals is underway.

The NivaSonix ULLISYS™ system is based on a flexible and expandable product platform, designed for both skin tightening (wrinkle reduction) and lipoplasty (fat emulsification) – multi-billion dollar market opportunities.

"We are pleased to receive the notice of allowance of our patent – this innovative, broad technology and product should benefit both patients and surgeons," commented Bobby Purkait, President and CEO of NivaSonix.

About NivaSonix:

NivaSonix, LLC is a privately funded, California limited liability company headquartered in Carpinteria, CA. NivaSonix, LLC is a technology based company involved in the research and development, manufacture and commercialization of non-invasive ultrasound medical device systems for aesthetic, dermatology and other cosmetic and personal care markets.  The Company is led by a highly experienced, cross-functional management team with direct experience in global commercialization of ultrasound based body contouring products.


'/>"/>
SOURCE NivaSonix, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. KemPharm, Inc. Receives Notice of Issuance from USPTO on Second Patent Protecting Companys ADHD Prodrug Technology
2. KemPharm, Inc. Receives Notice of Issuance From USPTO on Patent Protecting Companys ADHD Prodrug Technology
3. New Online Pharmacy Rx-webmasters.com Allows Customers to Pay Less for High-Quality Drugs
4. Social Media Research Service Allows Pharmaceutical Marketers to Monitor Brand Health
5. Usability Sciences Corporation Launches WebIQ Pharma - An Intelligent Survey Tool That Allows Pharma Sites to Measure and Improve Website Effectiveness
6. Healthcare Scoring System Allows Hospitals To Increase Charity Care
7. New Florida Law Allows Use of Instant Drug Tests On the Job Site
8. United States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food
9. UCB and PDL BioPharma Resolve Patent Disputes
10. ISTO Technologies Awarded Key Patent for NuQu™ Injectable Therapy for Degenerative Disc Disease
11. Generex Oncology Receives New Patent for AE37 Immunotherapeutic Cancer Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... -- Commended for their devotion to personalized service, SMP Pharmacy Solutions ... in the South Florida Business Journal,s 50 Fastest-Growing Companies, and ... the national specialty pharmacy has found its niche.  To that ... be honored by SFBJ as the 2017 Power Leader in ... receive his award in October, Bardisa said of the three ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/22/2017)... -- AVACEN Medical (AVACEN) announced that its CE-Marked AVACEN ... with the widespread pain associated with fibromyalgia in the ... Essex, England commented, "I had difficulty ... sleep at all, tremendous pain, with every movement sending ... AVACEN 100] enough, how this has and is helping ...
Breaking Medicine Technology:
(Date:10/13/2017)... OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... or dementia. However, many long-term care insurance companies have a waiver for care if ... the 90-day elimination period, when the family pays for care, is often waived, so ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
Breaking Medicine News(10 mins):